Detalhe da pesquisa
1.
Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.
Eur J Nucl Med Mol Imaging
; 51(5): 1361-1370, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38114616
2.
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy.
Ann Hematol
; 103(1): 259-268, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861736
3.
Reliability and practicability of PSMA-RADS 1.0 for structured reporting of PSMA-PET/CT scans in prostate cancer patients.
Eur Radiol
; 34(2): 1157-1166, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624414
4.
Decoding the signaling profile of hematopoietic progenitor kinase 1 (HPK1) in innate immunity: A proteomic approach.
Eur J Immunol
; 52(5): 760-769, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35099066
5.
Prognostic value of pre-infusion tumor growth rate for patients with lymphoma receiving chimeric antigen receptor T-cell therapy.
Cytotherapy
; 25(9): 986-992, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055322
6.
Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy.
Eur J Nucl Med Mol Imaging
; 50(5): 1406-1413, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513818
7.
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
Eur J Nucl Med Mol Imaging
; 50(8): 2466-2476, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951991
8.
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE.
Eur J Nucl Med Mol Imaging
; 50(11): 3390-3399, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37358620
9.
Validation of the SSTR-RADS 1.0 for the structured interpretation of SSTR-PET/CT and treatment planning in neuroendocrine tumor (NET) patients.
Eur Radiol
; 33(5): 3416-3424, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964768
10.
Increased visceral fat distribution and body composition impact cytokine release syndrome onset and severity after CD19 chimeric antigen receptor T-cell therapy in advanced B-cell malignancies.
Haematologica
; 107(9): 2096-2107, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172565
11.
Correction to: Nextgeneration PET/CT imaging in meningioma-first clinical experiences using the novel SSTRtargeting peptide [18F]SiTATE.
Eur J Nucl Med Mol Imaging
; 50(13): 4115, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642707
12.
The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via ß2 integrins (CD11/CD18).
Blood
; 123(12): 1887-96, 2014 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-24458438
13.
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on 18F-FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(5): 1692-1693, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32814980
14.
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors.
Radiol Oncol
; 58(2): 196-205, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38613843
15.
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients.
Radiol Oncol
; 2024 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861687
16.
Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT.
Diagn Interv Imaging
; 105(1): 15-25, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453859
17.
Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation.
Cancer Imaging
; 24(1): 70, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38849902
18.
Evaluation of MRI in the diagnostic accuracy of extrahepatic metastases in neuroendocrine tumors in comparison with the reference standard somatostatin-receptor-PET/CT.
Front Oncol
; 13: 1194152, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655102
19.
Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
Radiol Oncol
; 57(4): 436-445, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38038419
20.
Staging of lymphoma under chimeric antigen receptor T-cell therapy: reasons for discordance among imaging response criteria.
Cancer Imaging
; 23(1): 44, 2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189191